Skip to content

The effect of diquafosol sodium ophthalmic solution on visual function in patients following cataract surgery

The effect of diquafosol sodium ophthalmic solution on visual function in patients following cataract surgery - The effect of diquafosol sodium ophthalmic solutionin patients following cataract surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000015659
Enrollment
90
Registered
2014-11-11
Start date
2014-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Diquafosol sodium ophthalmic solution Artificial tears No treatment

Sponsors

Keio University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients who are diagnosed as the cataract by the aging of 40 to 85 years old and is going to perform an operation. 2) Patients with preoperative corrected visual acuity more than 0.4. 3) Operation method is trans-conjunctival single-plane incision. 2.4 mm incision fixed. 4) Patients who use the specified intraocular lens. 5) Patients who agree to study entry and can see an ophthalmologist for all observation periods.

Exclusion criteria

Exclusion criteria: 1) Patients who don't meet the above entry criteria. 2) Patients with progressive irregular corneal astigmatism. 3) Cataract by congenital, metabolic, prenatal infection, traumatic, harmful rays, radiation, inflammatory, drug-induced, atopic, systemic disease, a cause other than aging. 4) Patients whom primary doctor judged as inadequacy except for the above.

Design outcomes

Primary

MeasureTime frame
Visual function(functional visual acuity, refraction, and so on)

Secondary

MeasureTime frame
Symptoms (questionnaire, DEQS)

Countries

Japan

Contacts

Public ContactKazuno Negishi

Keio University School of Medicine Department of Ophthalmology

fwic7788@mb.infoweb.ne.jp03-5363-3821

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026